Health Care Innovation
Business & Economics
The Federal War Against Medical Technology
At about $75 billion annually, U.S. private-sector investment in medical technology is substantial, and a large body of research demonstrates that the economic returns to these investments are enormous. But emerging federal policies are likely to create powerful disincentives for the research and development of medical innovations, in particular, pharmaceuticals ...
Commentary
The Latest ObamaCare Assault On Health Care Innovation
The list of health services that ObamaCare requires all insurers to cover without co-pays or deductibles keeps growing. The latest additions include an array of womens wellness services and products: birth control, breast pumps, domestic violence counseling, and more. Of course, these additional benefits arent really free. They drive up ...
Commentary
Government Mandates Make Health Savings More Elusive
The Centers for Medicare and Medicaid Services recently released some data that show that the digital revolution continues to evade health care. Through mid-May, just 1,026 registered hospitals and physicians out of a possible 56,599 have demonstrated that they are using electronic medical records and other health information technology in ...
Commentary
Piping Up: Medical Innovation Critical To Bringing Down Health Care Costs
By the end of this decade, national health care spending is projected to amount to one-fifth of the country’s GDP. That’s more than four times military expenditures–and five times the amount spent each year on education. And that’s a conservative estimate. In a recent study, consulting firm Deloitte revealed that ...
Commentary
Death Trap Democrats
Despite November’s New Deal magnitude political earthquake, surviving House Democrats just laughed off their historic 63 seat loss and reelected ultra-left San Francisco Democrat Nancy Pelosi as House Minority Leader, a position she will now apparently hold for life. Somehow Democrats are convinced that the American people will come to ...
Commentary
Price of compassion for cancer patients
There was a time in this country when European-style health care served as a cautionary tale. Today it is beginning to look like something to envy. Future generations wishing to identify the moment the shift took place should look to Dec. 16, 2010. That was the day the U.S. Food ...
Commentary
Enabling The Next Biomedical Revolution
In his State of the Union address President Obama singled out biomedical innovation as a key driver of America’s future prosperity. This sector has indeed generated tens of thousands of jobs, attracted billions in investment and created advanced medical treatments for Americans. A promising new area of biomedicine, called biologics, ...
Commentary
Have-nots lose on Avastin ruling
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA’s decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin ...
Commentary
Blue-Sky Thinking on Health Reform: An Interstate Compact for Health Insurance
Key Points Health insurance is the only line of insurance regulated by the federal government, but federal control has created and deepened the health crisis. Obamacare attempts to conscript states to do the dirty work of limiting peoples choice of health benefits. States have ensured portability and competition in other ...
Commentary
FDA’s Decision On Avastin Will Set the Standard
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform. At a Senate Finance Committee hearing in November, the new chief of Medicare and ...
The Federal War Against Medical Technology
At about $75 billion annually, U.S. private-sector investment in medical technology is substantial, and a large body of research demonstrates that the economic returns to these investments are enormous. But emerging federal policies are likely to create powerful disincentives for the research and development of medical innovations, in particular, pharmaceuticals ...
The Latest ObamaCare Assault On Health Care Innovation
The list of health services that ObamaCare requires all insurers to cover without co-pays or deductibles keeps growing. The latest additions include an array of womens wellness services and products: birth control, breast pumps, domestic violence counseling, and more. Of course, these additional benefits arent really free. They drive up ...
Government Mandates Make Health Savings More Elusive
The Centers for Medicare and Medicaid Services recently released some data that show that the digital revolution continues to evade health care. Through mid-May, just 1,026 registered hospitals and physicians out of a possible 56,599 have demonstrated that they are using electronic medical records and other health information technology in ...
Piping Up: Medical Innovation Critical To Bringing Down Health Care Costs
By the end of this decade, national health care spending is projected to amount to one-fifth of the country’s GDP. That’s more than four times military expenditures–and five times the amount spent each year on education. And that’s a conservative estimate. In a recent study, consulting firm Deloitte revealed that ...
Death Trap Democrats
Despite November’s New Deal magnitude political earthquake, surviving House Democrats just laughed off their historic 63 seat loss and reelected ultra-left San Francisco Democrat Nancy Pelosi as House Minority Leader, a position she will now apparently hold for life. Somehow Democrats are convinced that the American people will come to ...
Price of compassion for cancer patients
There was a time in this country when European-style health care served as a cautionary tale. Today it is beginning to look like something to envy. Future generations wishing to identify the moment the shift took place should look to Dec. 16, 2010. That was the day the U.S. Food ...
Enabling The Next Biomedical Revolution
In his State of the Union address President Obama singled out biomedical innovation as a key driver of America’s future prosperity. This sector has indeed generated tens of thousands of jobs, attracted billions in investment and created advanced medical treatments for Americans. A promising new area of biomedicine, called biologics, ...
Have-nots lose on Avastin ruling
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA’s decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin ...
Blue-Sky Thinking on Health Reform: An Interstate Compact for Health Insurance
Key Points Health insurance is the only line of insurance regulated by the federal government, but federal control has created and deepened the health crisis. Obamacare attempts to conscript states to do the dirty work of limiting peoples choice of health benefits. States have ensured portability and competition in other ...
FDA’s Decision On Avastin Will Set the Standard
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform. At a Senate Finance Committee hearing in November, the new chief of Medicare and ...
